Clinical Trial Update: Naloxone for Optimizing Hypoxemia Of Lung Donors [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial updates on naloxone use to optimize hypoxemia in lung donors, with Phase 2 and Phase 3 completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Death
• Lung Transplantation

Drugs mentioned

• Naloxone (Naloxone)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Brain Death, Organ Donors | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-10-16